These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

236 related articles for article (PubMed ID: 2182239)

  • 1. Summary of U.S. clinical trials program for evaluation of anistreplase.
    Anderson JL
    Clin Cardiol; 1990 Mar; Suppl 5():V33-8; discussion V67-72. PubMed ID: 2182239
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Multicenter reperfusion trial of intravenous anisoylated plasminogen streptokinase activator complex (APSAC) in acute myocardial infarction: controlled comparison with intracoronary streptokinase.
    Anderson JL; Rothbard RL; Hackworthy RA; Sorensen SG; Fitzpatrick PG; Dahl CF; Hagan AD; Browne KF; Symkoviak GP; Menlove RL
    J Am Coll Cardiol; 1988 Jun; 11(6):1153-63. PubMed ID: 3284943
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Variability of thrombolytic coronary reperfusion: an angiographic study of streptokinase and anistreplase.
    Sorensen SG; Hackworthy RA; Fitzpatrick PG; Menlove R; Anderson JL
    Clin Cardiol; 1990 Mar; Suppl 5():V15-9; discussion V27-32. PubMed ID: 2182235
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Anistreplase: a novel thrombolytic agent for acute myocardial infarction.
    Marinac JS; North DS; Stringer KA
    DICP; 1990 Jun; 24(6):607-15. PubMed ID: 2193460
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Coronary reperfusion by anistreplase (Eminase) used intravenously during the acute phase of myocardial infarction].
    Monassier JP; Hanssen M; Fritz A; Katz O; Hertzog M
    Arch Mal Coeur Vaiss; 1990 Feb; 83 Spec No 1():21-4. PubMed ID: 2108642
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Acylated plasminogen-streptokinase activator complex: a new approach to thrombolytic therapy.
    Crabbe SJ; Grimm AM; Hopkins LE
    Pharmacotherapy; 1990; 10(2):115-26. PubMed ID: 2140889
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Comparison of intravenous anisoylated plasminogen streptokinase activator complex with intracoronary streptokinase in acute myocardial infarction.
    Bonnier JJ
    Drugs; 1987; 33 Suppl 3():151-3. PubMed ID: 3315583
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Reperfusion, patency and reocclusion with anistreplase (APSAC) in acute myocardial infarction.
    Anderson JL
    Am J Cardiol; 1989 Jul; 64(2):12A-17A; discussion 24A-26A. PubMed ID: 2662737
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Tolerance and complications in a multicenter trial of intravenous APSAC and intracoronary streptokinase in acute myocardial infarction.
    Rothbard RL; Anderson JL; Fitzpatrick PG; Hakworthy RA; Sorensen SG; Marder VJ
    Clin Cardiol; 1990 Mar; Suppl 5():V11-4; discussion V27-32. PubMed ID: 2182234
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Comparison of intravenous anisoylated plasminogen streptokinase activator complex and intracoronary streptokinase in acute myocardial infarction.
    Bonnier HJ; Visser RF; Klomps HC; Hoffmann HJ
    Am J Cardiol; 1988 Jul; 62(1):25-30. PubMed ID: 3289357
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Development and evaluation of anisoylated plasminogen streptokinase activator complex (APSAC) as a second generation thrombolytic agent.
    Anderson JL
    J Am Coll Cardiol; 1987 Nov; 10(5 Suppl B):22B-27B. PubMed ID: 3312369
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Angiographic patency study of anistreplase versus streptokinase in acute myocardial infarction.
    Hogg KJ; Gemmill JD; Burns JM; Lifson WK; Rae AP; Dunn FG; Hillis WS
    Lancet; 1990 Feb; 335(8684):254-8. PubMed ID: 1967720
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Thrombolytic treatment in acute myocardial infarction.
    Verstraete M
    Circulation; 1990 Sep; 82(3 Suppl):II96-109. PubMed ID: 2118432
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Anistreplase: a new thrombolytic for the treatment of acute myocardial infarction.
    Munger MA; Forrence EA
    Clin Pharm; 1990 Jul; 9(7):530-40. PubMed ID: 2198125
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Long-term effects of intravenous anistreplase in acute myocardial infarction: final report of the AIMS study. AIMS Trial Study Group.
    Lancet; 1990 Feb; 335(8687):427-31. PubMed ID: 1968167
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Reperfusion in acute myocardial infarction. A multicentre randomised trial of early intracoronary streptokinase and intravenous anisoylated plasminogen streptokinase activator complex in the United States.
    Anderson JL
    Drugs; 1987; 33 Suppl 3():154-62. PubMed ID: 3315584
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Effects on infarct size and left ventricular function of early intravenous injection of anistreplase in acute myocardial infarction. The APSIM Study Investigators.
    Bassand JP; Bernard Y; Lusson JR; Machecourt J; Cassagnes J; Borel E
    Clin Cardiol; 1990 Mar; Suppl 5():V39-44; discussion V67-72. PubMed ID: 2182240
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Coronary thrombolysis during acute myocardial infarction by intravenous BRL 26921, a new anisoylated plasminogen-streptokinase activator complex.
    Kasper W; Meinertz T; Wollschläger H; Bonzel T; Wolff P; Drexler H; Hofmann T; Zeiher A; Just H
    Am J Cardiol; 1986 Sep; 58(6):418-21. PubMed ID: 3529908
    [TBL] [Abstract][Full Text] [Related]  

  • 19. An interim report of the efficacy and safety of anisoylated plasminogen streptokinase activator complex (APSAC).
    Johnson ES; Cregeen RJ
    Drugs; 1987; 33 Suppl 3():298-311. PubMed ID: 3315612
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Effects of anistreplase on coronary patency in acute myocardial infarction].
    Pacouret G; Charbonnier B
    Arch Mal Coeur Vaiss; 1990 Feb; 83 Spec No 1():25-9. PubMed ID: 2108643
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.